New Key Statistics Module, Z-Score and F-Score
SHSE:603079 Key Ratios
Market Cap ¥ M | 2,779.88 |
Enterprise Value ¥ M | 2,692.27 |
P/E(ttm) | -- |
PE Ratio without NRI | 84.84 |
Forward PE Ratio | -- |
Price/Book | 2.18 |
Price/Sales | 3.05 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.32 |
Revenue (TTM) ¥ M | 792.00 |
EPS (TTM) ¥ | -0.17 |
Beneish M-Score | -3.31 |
10-y EBITDA Growth Rate % | -5.00 |
5-y EBITDA Growth Rate % | -19.00 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -199.83 |
EV-to-EBITDA | -199.83 |
PEG | -- |
Shares Outstanding M | 171.19 |
Net Margin (%) | -3.62 |
Operating Margin % | 3.51 |
Pre-tax Margin (%) | -1.91 |
Quick Ratio | 1.93 |
Current Ratio | 2.78 |
ROA % (ttm) | -1.67 |
ROE % (ttm) | -2.27 |
ROIC % (ttm) | 3.56 |
Dividend Yield % | 0.38 |
Altman Z-Score | 4.32 |
SHSE:603079 Number of Guru Trades
SHSE:603079 Volume of Guru Trades
Gurus Latest Trades with SHSE:603079
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:603079 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhejiang Shengda Bio-Pharm Co Ltd Insider Transactions
No Available Data